- Home
- STGW vs SLP Comparison
STGW vs SLP Comparison
Compare STGW & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STGW
- SLP
- Stock Information
- Founded
- STGW 1980
- SLP 1996
- Country
- STGW United States
- SLP United States
- Employees
- STGW N/A
- SLP N/A
- Industry
- STGW
- SLP EDP Services
- Sector
- STGW
- SLP Technology
- Exchange
- STGW Nasdaq
- SLP Nasdaq
- Market Cap
- STGW 683.2M
- SLP 675.9M
- IPO Year
- STGW N/A
- SLP 1997
- Fundamental
- Price
- STGW $4.45
- SLP $17.16
- Analyst Decision
- STGW Buy
- SLP Buy
- Analyst Count
- STGW 5
- SLP 7
- Target Price
- STGW $8.60
- SLP $40.40
- AVG Volume (30 Days)
- STGW 1.9M
- SLP 454.9K
- Earning Date
- STGW 07-31-2025
- SLP 07-02-2025
- Dividend Yield
- STGW N/A
- SLP 0.35%
- EPS Growth
- STGW N/A
- SLP N/A
- EPS
- STGW N/A
- SLP 0.36
- Revenue
- STGW $2,822,897,000.00
- SLP $78,564,000.00
- Revenue This Year
- STGW $4.88
- SLP $27.66
- Revenue Next Year
- STGW $11.07
- SLP $6.75
- P/E Ratio
- STGW N/A
- SLP $47.57
- Revenue Growth
- STGW 9.64
- SLP 21.49
- 52 Week Low
- STGW $4.03
- SLP $17.05
- 52 Week High
- STGW $8.18
- SLP $49.72
- Technical
- Relative Strength Index (RSI)
- STGW 43.53
- SLP 18.67
- Support Level
- STGW $4.28
- SLP $18.66
- Resistance Level
- STGW $5.05
- SLP $28.65
- Average True Range (ATR)
- STGW 0.23
- SLP 1.74
- MACD
- STGW 0.01
- SLP -1.05
- Stochastic Oscillator
- STGW 41.18
- SLP 3.78
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.